Rapport Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $6.43-$29.74 |
Market Cap | $541.6M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.82 |
News
See moreYahoo Finance • 4 days ago
JMP reiterates Market Outperform rating on Rapport Therapeutics stock
Yahoo Finance • 2 months ago
Rapport Therapeutics Hosts Investor and Analyst Day; Provides Corporate Updates
Yahoo Finance • 2 months ago
Rapport Therapeutics to Host 2025 Investor and Analyst Day
Yahoo Finance • 4 months ago
Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting
About
CEO | Mr. Abraham N. Ceesay M.B.A. |
Address | 1325 Boylston Street, Boston, MA, United States, 02215 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 69 |
